» Articles » PMID: 22146593

Unilateral Nigrostriatal 6-hydroxydopamine Lesions in Mice I: Motor Impairments Identify Extent of Dopamine Depletion at Three Different Lesion Sites

Overview
Journal Behav Brain Res
Date 2011 Dec 8
PMID 22146593
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The unilateral 6-hydroxydopamine mouse lesion models of Parkinson's disease have received increasing attention in recent years, but comparison of the different lesion models was largely focused at a histological level. An extensive behavioural comparison between different mouse models on tests of motor function has yet to be carried out, to pin point tests that accurately discriminate between different extents of dopaminergic depletion. In the present study we examine the consequences of injection of the toxin at three sites along the nigrostriatal tract (substantia nigra, medial forebrain bundle, and striatum) on a broad range of simple motor tasks, and on the dopaminergic pathology. All lesion groups demonstrated marked behavioural deficits and displayed distinct profiles of degeneration along the nigrostriatal dopamine pathway. Tests that correlated closely with the level of substantia nigra cell loss included the corridor, cylinder and balance beam tests, the rotarod, inverted cage lid and three types of rotational assessment (spontaneous, amphetamine-induced and apomorphine-induced). Specific tasks are identified which are capable of distinguishing a near-complete lesion, with amphetamine rotation, corridor and cylinder tests showing the highest correlations with levels of nigral cell loss. Performance in the different behavioural tests was associated with distinct profiles of cell loss in the SN and VTA. We provide a comprehensive behavioural assessment of lesion-induced deficits in mouse models of PD, which should facilitate selection of the most appropriate lesion model and most sensitive behavioural tests for use in future studies investigating therapeutic interventions.

Citing Articles

Enhancing striatal acetylcholine facilitates dopamine release and striatal output in parkinsonian mice.

Li H, Chen Z, Tan Y, Luo H, Lu C, Gao C Cell Biosci. 2024; 14(1):146.

PMID: 39627827 PMC: 11616140. DOI: 10.1186/s13578-024-01328-z.


Aqueous extract of leaf exerts an anti-inflammatory effect in a murine model of Parkinson's disease induced by 6-OHDA.

Cardoso V, Valente-Amaral A, Monteiro R, Meira C, de Meira N, Da Silva M Front Neurosci. 2024; 18:1351718.

PMID: 38449740 PMC: 10914943. DOI: 10.3389/fnins.2024.1351718.


Characterization of graded 6-Hydroxydopamine unilateral lesion in medial forebrain bundle of mice.

Cui J, Zhao D, Xu M, Li Z, Qian J, Song N Sci Rep. 2024; 14(1):3721.

PMID: 38355892 PMC: 10866897. DOI: 10.1038/s41598-024-54066-0.


N-Acetylcysteine Treatment May Compensate Motor Impairments through Dopaminergic Transmission Modulation in a Striatal 6-Hydroxydopamine Parkinson's Disease Rat Model.

Caridade-Silva R, Araujo B, Martins-Macedo J, Teixeira F Antioxidants (Basel). 2023; 12(6).

PMID: 37371987 PMC: 10295771. DOI: 10.3390/antiox12061257.


Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson's disease in animal models.

Li J, Li N, Wei J, Feng C, Chen Y, Chen T NPJ Parkinsons Dis. 2022; 8(1):175.

PMID: 36550118 PMC: 9780305. DOI: 10.1038/s41531-022-00440-6.